Your Cart Is Empty!
The Asia-Pacific IVF services market was evaluated at $1.9 billion in 2014 and is estimated to garner $3.5 billion by 2020, registering a CAGR of 10.8% during the forecast period 20152020. This market is expected to witness significant growth during the forecast period on account of the delayed pregnancies, rising infertility rates due to dysfunctional lifestyles, environmental pollution, increasing disposable incomes and emergence of newer fertility tourism destinations. In addition, several academic institutions are collaborating with fertility hospitals and clinics to conduct extensive research & development activities, and provide more effective and better treatment facilities. The other factors, namely technological advancements, utilization of intra-cytoplasmic sperm injection (ICSI) technique and growing popularity of donor egg IVF methods would collectively boost the success rates of IVF cycles. However, factors such as high costs associated with the treatment, lack of favorable IVF reimbursement policies and lower health awareness, especially in the underdeveloped Asia-Pacific countries, such as Nepal and Myanmar, are the major factors hampering the market growth. In addition, ethical concerns regarding the parental rights are expected to have a restraining effect on the growth of the market.
The Asia-Pacific IVF services market is segmented on the basis of end users, cycles type and country-wise analysis. Based on the type of cycle performed, the market is categorized into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh IVF cycle is the largest revenue-generating segment, owing to increasing preference of IVF for infertility treatment. The end users market is categorized into fertility clinics, hospitals, surgical centers and clinical research institutes. In 2014, fertility clinics were the leading end user segments, accounting for about one-fifths of the overall market share.
Geographically, this market is segmented into India, China, Japan, Vietnam, Korea, Australia, New Zealand, Thailand, Malaysia, Indonesia, Philippines, Singapore, and other Asia-Pacific countries. In terms of revenue, Japan dominates the Asia-Pacific IVF market, owing to the large consumer base, rapid adoption of advanced technologies and availability of skilled workforce. However, the Indian IVF market is anticipated to register a promising CAGR of 14.7% during the forecast period. This is mainly supplemented by factors, such as the rising trend of fertility tourism, favorable regulation of surrogacy and donor services, and wide availability of IVF clinics. Based on number of cycles performed, Japan is the leading country, accounting for a major share of the market and is expected to maintain this trend throughout the forecast period. However, the India IVF market, in terms of number of cycles performed, is anticipated to grow at a promising CAGR of 16.3% during the study period.
KEY MARKET BENEFITS:
This report provides an in-depth analysis of the Asia-Pacific IVF market across seven major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.
This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.
The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2014 to 2020.
Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.
ASIA-PACIFIC IN-VITRO FERTILIZATION SERVICES MARKET KEY SEGMENTS:
The Asia-Pacific IVF market is segmented on the basis of end users, cycle type and country:
By End Users (Value and Volume)
Clinical research institutes
By Cycle Type, (Value and Volume)
Fresh cycle (non-donor)
Thawed IVF cycle (non-donor)
Donor egg IVF cycles
By Cycle Type Country Level Analysis (Value and Volume)
EMD Serono, Inc.Cook Medical, Inc.
4.7.2 Vitrolife AB
4.7.3 Centre for Reproductive Medicine
4.7.4 Reproductive and genetic Hospital Citic-Xiangya
4.7.5 Shenyang Hospital
4.7.6 Shandong Provincial Hospital5.7.1 Sun Pharmaceutical Industries Ltd.
5.7.2 Trivector Origio Scientific Pvt. Ltd
5.7.3 Lab IVF Asia Pte. Ltd.
5.7.4 LG Life Sciences.
5.7.5 Cadila Healthcare Ltd. (Zydus Cadila group)
5.7.6 Bourn Hall Clinic
5.7.7 Morpheus IVF Fertility Center
5.7.8 Southend Fertility and IVF Centre
5.7.9 Nova IVI Fertility
5.7.10 Bloom Fertility Center
5.7.11 Manipal Ankur
5.7.12 CloudnineFertility Associates
7.7.2 Fertility Plus
7.7.3 Reporomed Genea Biomedx
8.7.2 Thermo Fisher Scientific Inc.
8.7.3 Virtus Health
8.7.4 Monash IVF
8.7.5 City Fertility
8.7.6 Flinders FertilityEMD Serono, Inc.
9.7.2 IVF Namba Clinic
9.7.3 Iwaki Womens Clinic
9.7.4 Sanno Hospital NUH IVF Centre
10.2.8.2 Mount Elizabeth Fertility Center
10.2.8.3 Thomson Fertility Centre
10.2.8.4 Raffles Fertility CentreSubang Fertility Center Subang Jaya Hospital, Subang
10.3.7.2 Concept Fertility Center
10.3.7.3 TMC Fertility CenterMorula IVF
10.4.7.2 Yasmin IVF
10.4.7.3 Aster Fertility Clinic
10.4.7.4 Fertility Centre, Siloam Hospitals SurabanaVictory Art Lab
10.5.7.2 CRM-MIA-PhilippinesBangkok Fertility Center
10.6.7.2 Siriraj Hospital
10.6.7.3 Ramathibodi Hospital
10.6.7.4 Perfect Woman Institute Piyavate Hospital
10.6.7.5 Jetanin Institute for Assisted ReproductionIVF Lab Tu Du Hospital Vietnam
10.7.7.2 IVF Van Hanh
10.7.7.4 Tu Du - Ho Chi Minh City Vietnam
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.